Shenzhen New Industries Biomedical Engineering Co., Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. faced a decline in stock performance, dropping 3.01% on June 2, 2026. The company has struggled with a year-to-date decrease of 19.7% and a 24.7% loss over the past year, amid mixed financial metrics and declining profits.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a decline in its stock today, contrasting with gains in the broader market. Over the past week and year, the company has faced significant downturns, while maintaining a dividend yield of 2.86% and showing mixed financial metrics.

Shenzhen New Industries Biomedical Engineering Co., Ltd. has recently experienced a change in its evaluation, influenced by shifts in financial metrics and market position. The company faces challenges, including declining profits and a rising debt-equity ratio, which have impacted its overall financial performance and valuation dynamics.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a significant stock decline today, reflecting broader market trends. The company has experienced a cumulative drop over the past week and month, with year-to-date losses also notable. Financial metrics indicate challenges in long-term growth despite some positive performance indicators.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Over the past week and month, the stock has faced notable decreases, and its one-year return is substantially negative compared to the China Shanghai Composite. Key financial metrics indicate ongoing challenges in the sector.

Shenzhen New Industries Biomedical Engineering Co., Ltd. faced a significant stock decline, reaching an intraday low and showing a notable decrease over the past week and month. The company has struggled in the long term, with a substantial drop in performance compared to the China Shanghai Composite and a challenging outlook in the pharmaceuticals sector.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a significant intraday increase on March 6, 2026, contrasting with the broader market's modest gain. Despite a recent uptick, the company has struggled over the past year, reporting a decline in profits and underperforming compared to the China Shanghai Composite.

Shenzhen New Industries Biomedical Engineering Co., Ltd. saw a notable increase in its stock price today, reaching an intraday high. However, the company has struggled over the past year, with a significant decline in returns compared to the broader market. Its market capitalization is CNY 36,352 million, and it maintains a dividend yield of 2.81%.